Search for: "Brian Cordery"
Results 1 - 20
of 28
Sort by Relevance
|
Sort by Date
14 Dec 2022, 11:59 pm
Kluwer IP Law interviewed Brian Cordery, partner at UK law firm Bristows, about his expectations. [read post]
3 Dec 2019, 6:59 am
Brian Cordery and Matthew RaynorOn 29 November 2019, the Patents Court of England and Wales handed down it decision revoking Conversant’s UK patent relating to an improved user interface on smartphone devices. [read post]
16 Sep 2019, 2:10 am
In the referring decision [2019] EWHC 388 (Pat), which was previously discussed on this blog by Brian Cordery and Laura Reynolds, Arnold J held that an SPC could not validly issue in the case at hand because the basic patent was found to be invalid in a parallel first-instance decision. [read post]
23 Jul 2019, 8:23 am
"Henry's clarity of thought and exceptional communication skills served him well as a Judge," Brian Cordery recalls. [read post]
27 Mar 2019, 5:28 am
Brian Cordery and Claire Phipps-JonesThe UK Supreme Court today handed down its decision in Actavis v ICOS. [read post]
22 Mar 2019, 4:48 am
Brian Cordery and Laura ReynoldsIn a post yesterday our colleagues at Vossius commented on the CJEU’s decision, which had just been handed down in Abraxis*. [read post]
4 Mar 2019, 8:44 am
Brian Cordery and Laura ReynoldsOn Friday 1 March 2019, Arnold J handed down his judgment in the patent dispute between Eli Lilly and Genentech regarding IL-17A/F antibodies*1. [read post]
14 Nov 2018, 8:14 am
Brian Cordery, Claire Phipps-Jones, Adrian Chew and Emma MunceyToday, after nine months of waiting, the decision of the UK Supreme Court in the pregabalin litigation was handed down. [read post]
3 Apr 2018, 7:15 am
Brian Cordery and Rachel MumbyWise readers will know that when it comes to matters of the heart, it is often best not to interfere. [read post]
9 Mar 2018, 4:52 am
Brian Corderyby Claire Wilson & Brian Cordery Around this time last year, in Edwards Lifesciences v Boston Scientific [2017], His Honour Judge Hacon (sitting as a High Court Judge) had the opportunity to analyse two interesting aspects of UK patent law: (i) the law of implied disclosures and anticipation; and (ii) the importance of so-called secondary evidence in the evaluation of inventive step. [read post]
16 Jan 2018, 2:15 am
Brian Cordery and Gregory Baconby Greg Bacon There has been much excitement and comment amongst the UK patent profession following the Supreme Court’s decision in Actavis v Eli Lilly [2017] UKSC 48 (see previous comment here) on patent claim construction. [read post]
30 Dec 2017, 2:13 pm
Andrew’s note, and Bristows “Review of the Year” when Brian [Cordery] finishes it, are the two must-haves short guides to patents for anyone with an exam coming up. [read post]
4 Dec 2017, 7:18 am
Brian Cordery and Rachel MumbyWhilst many in show business have long lived by the adage “never work with children or animals” for fear of what might ensue, patent litigators in the UK have long been known to take a similar approach to experiments, avoiding them if at all possible for fear of the results. [read post]
7 Nov 2017, 3:26 am
Brian Cordery and Emma MunceyLast year, Actavis, Teva and Mylan (“Actavis”) sought revocation in the English Patents Court of two patents relating to tadalafil, which is sold by Eli Lilly (“Lilly”) as the active ingredient in CIALIS® to treat erectile dysfunction and pulmonary arterial hypertension. [read post]
26 Jul 2017, 3:49 am
” This focus on “immateriality” has begged the question in other posts published on this blog as to whether this judgment marks the return of the “pith and marrow doctrine” (please see the post published by Brian Cordery on 13 July 2017). [read post]
26 Jul 2017, 3:49 am
” This focus on “immateriality” has begged the question in other posts published on this blog as to whether this judgment marks the return of the “pith and marrow doctrine” (please see the post published by Brian Cordery on 13 July 2017). [read post]
25 Apr 2017, 6:00 am
As it turned out, it was 99% about plausibility and only 1% about Second Medical Use.After an introduction by Brian Cordery (Bristows), who highlighted the importance that the plausibility check has gained in patent validity matters in the UK, Floyd LJ explained the complete history of plausibility in less than 5 minutes and with 5 decision. [read post]
7 Dec 2016, 11:58 pm
The same panel of experts - Claire Baldock (Boult Wade Tenant), Brian Cordery (Bristows) and Stuart Baran (3 New Square) - that presented at the first seminar reconvened last week to revisit the issues and grapple with new ones raised by the two most recent judgments. [read post]
18 Nov 2016, 12:44 am
The case also provides a useful comparator for the England and Wales Court of Appeal’s judgment on 13 October 2016 in Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (EWCA Judgment) (covered by Brian Cordery of Bristows in ‘Pain and Plausibility – the Lyrica Appeal’), particularly with respect to how Australian and English law determine sufficiency and infringement of Swiss-style claims. [read post]
15 Nov 2016, 6:06 am
No, its not the start of a joke, but the identities of the three speakers who take the form of Claire Baldock (Boult Wade Tennant), Stuart Baran (Three New Square) and Brian Cordery (Bristows) What: Bringing their unique perspectives, the speakers will be analyzing the Court of Appeal's decision, dealing with the three main aspects of validity, abuse of process and infringement. [read post]
